18/06/2026
🎯During International Neuroblastoma Awareness Week, we raise awareness of high-risk neuroblastoma, which accounts for 15% of cancer-related deaths in children.
The project is developing liquid biopsy assays and a digital decision-support tool to improve monitoring for children with relapsed neuroblastoma, while reducing reliance on invasive procedures, improving quality of life, and setting new standards of care across Europe.
🎥 Learn more in this video interview made by EU Cancer Mission: https://www.youtube.com/watch?v=vCFuubVNbxo
St. Anna Kinderkrebsforschung Prinses Máxima Centrum voor kinderoncologie EU Science & Innovation
MONALISA is developing innovative liquid biopsy assays and a digita...